Repro Financial Statements From 2010 to 2026

KRMD Stock  USD 4.67  0.30  6.86%   
Repro Med's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Repro Med's valuation are provided below:
Gross Profit
24.3 M
Profit Margin
(0.1)
Market Capitalization
211.2 M
Enterprise Value Revenue
5.2838
Revenue
39.1 M
There are over one hundred nineteen available trending fundamental ratios for Repro Med Systems, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Repro Med's recent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 106 M. The current year's Enterprise Value is expected to grow to about 99.4 M

Repro Med Total Revenue

40.63 Million

Check Repro Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repro Med's main balance sheet or income statement drivers, such as Depreciation And Amortization of 933.3 K, Interest Expense of 159.1 K or Total Revenue of 40.6 M, as well as many indicators such as Price To Sales Ratio of 4.95, Dividend Yield of 0.0031 or PTB Ratio of 9.91. Repro financial statements analysis is a perfect complement when working with Repro Med Valuation or Volatility modules.
  
Build AI portfolio with Repro Stock
Check out the analysis of Repro Med Correlation against competitors.

Repro Med Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets32.9 M31.3 M18.9 M
Slightly volatile
Short and Long Term Debt Total4.8 M4.6 M1.7 M
Slightly volatile
Total Current Liabilities8.7 M8.3 M3.2 M
Slightly volatile
Cash11.6 M11 M8.4 M
Slightly volatile
Non Current Assets Total9.8 M9.3 MM
Slightly volatile
Non Currrent Assets Other108.1 K113.8 K407.7 K
Slightly volatile
Net Receivables7.2 M6.9 M2.9 M
Slightly volatile
Good Will7.3 K7.7 K8.6 K
Slightly volatile
Common Stock Total Equity373.2 K561.9 K422 K
Slightly volatile
Short Term Investments1.8 M1.7 M980 K
Slightly volatile
Liabilities And Stockholders Equity32.9 M31.3 M18.9 M
Slightly volatile
Non Current Liabilities Total3.9 M3.7 M1.4 M
Slightly volatile
Inventory1.8 M3.2 M2.6 M
Slightly volatile
Total Liabilities12.6 M12 M4.5 M
Slightly volatile
Property Plant And Equipment Gross13 M12.3 M3.9 M
Slightly volatile
Total Current Assets23.1 M22 M14.9 M
Slightly volatile
Intangible Assets881.8 K839.8 K500.4 K
Slightly volatile
Short Term Debt950.3 K905 K441.2 K
Slightly volatile
Other Current Liabilities5.8 M5.5 MM
Slightly volatile
Total Stockholder Equity20.3 M19.3 M14.2 M
Slightly volatile
Property Plant And Equipment Net8.8 M8.3 MM
Slightly volatile
Accounts PayableM1.9 M846.7 K
Slightly volatile
Cash And Short Term Investments11.6 M11 M8.5 M
Slightly volatile
Common Stock Shares Outstanding37.9 M52.7 M39.7 M
Slightly volatile
Other Current Assets528.4 K862.3 K743.7 K
Slightly volatile
Other Stockholder Equity55.2 M52.6 M20.2 M
Slightly volatile
Common Stock399.9 K567.8 K424.8 K
Slightly volatile
Current Deferred Revenue2.1 MM676.8 K
Slightly volatile
Other Liabilities21.7 K22.9 K80.1 K
Slightly volatile
Net Tangible Assets19.3 M35.1 M17.1 M
Slightly volatile
Other Assets4.9 M4.7 M1.4 M
Slightly volatile
Capital Surpluse53.4 M50.9 M21 M
Slightly volatile
Property Plant Equipment4.7 M4.5 M1.9 M
Slightly volatile
Net Invested Capital25.6 M19.6 M16.5 M
Slightly volatile
Capital Stock511.1 K567.8 K447.4 K
Slightly volatile
Net Working Capital21 M13.7 M13.4 M
Slightly volatile
Long Term Debt Total2.1 K2.4 K2.6 K
Slightly volatile
Capital Lease Obligations2.4 M4.3 M1.4 M
Slightly volatile
Non Current Liabilities Other4.9 M4.7 M1.6 M
Slightly volatile
Short and Long Term Debt305.5 K244 K451.3 K
Slightly volatile

Repro Med Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization933.3 K888.8 K433.2 K
Slightly volatile
Total Revenue40.6 M38.7 M19.7 M
Slightly volatile
Gross Profit25.8 M24.5 M12 M
Slightly volatile
Other Operating Expenses48.4 M46.1 M21.9 M
Slightly volatile
Research Development6.3 MMM
Slightly volatile
Cost Of Revenue14.9 M14.2 M7.6 M
Slightly volatile
Total Operating Expenses33.5 M31.9 M14.3 M
Slightly volatile
Selling General Administrative26.1 M24.9 M11.8 M
Slightly volatile
Interest Income536.9 K511.3 K153.2 K
Slightly volatile
Net Interest Income536.9 K511.3 K139.7 K
Slightly volatile
Reconciled Depreciation575.3 KM466.3 K
Slightly volatile
Extraordinary Items10.7 K12.1 K13.2 K
Slightly volatile
Non RecurringM2.2 M2.4 M
Slightly volatile
Non Operating Income Net Other115.5 K121.6 K110.9 K
Slightly volatile

Repro Med Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow13.9 M13.2 M8.3 M
Slightly volatile
Depreciation1.1 MM456.1 K
Slightly volatile
Dividends Paid223.1 K212.5 K178.4 K
Slightly volatile
Capital Expenditures1.6 M1.5 M840.8 K
Slightly volatile
End Period Cash Flow11.6 M11 M8.5 M
Slightly volatile
Stock Based Compensation3.2 MM1.3 M
Slightly volatile
Cash Flows Other Operating206.3 K217.2 K671.6 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.954.723.9168
Slightly volatile
Dividend Yield0.00310.00220.0024
Slightly volatile
PTB Ratio9.919.446.1249
Slightly volatile
Days Sales Outstanding36.1858.5649.5772
Very volatile
Book Value Per Share0.350.330.3256
Slightly volatile
Average Payables875.3 K833.6 K673.9 K
Slightly volatile
Stock Based Compensation To Revenue0.07370.07020.0455
Slightly volatile
Capex To Depreciation1.11.311.7376
Pretty Stable
PB Ratio9.919.446.1249
Slightly volatile
EV To Sales4.84.573.5988
Slightly volatile
Inventory Turnover2.053.952.9898
Very volatile
Days Of Inventory On Hand17795.56138
Very volatile
Payables Turnover8.176.7212.4898
Slightly volatile
Average Inventory5.9 M5.6 M3.7 M
Slightly volatile
Research And Ddevelopement To Revenue0.150.140.0702
Slightly volatile
Capex To Revenue0.02690.03470.0405
Pretty Stable
Cash Per Share0.20.190.1927
Slightly volatile
Days Payables Outstanding71.3356.2438.2729
Slightly volatile
Income Quality0.04980.04740.7574
Slightly volatile
Intangibles To Total Assets0.03330.03090.0313
Pretty Stable
Current Ratio3.582.395.6836
Slightly volatile
Tangible Book Value Per Share0.330.320.3139
Slightly volatile
Receivables Turnover9.476.457.6962
Very volatile
Shareholders Equity Per Share0.350.330.3256
Slightly volatile
Debt To Equity0.290.270.1053
Slightly volatile
Capex Per Share0.02680.02550.018
Slightly volatile
Average Receivables3.6 M3.4 M2.3 M
Slightly volatile
Revenue Per Share0.690.660.448
Slightly volatile
Interest Debt Per Share0.08230.07840.0314
Slightly volatile
Debt To Assets0.330.170.0802
Slightly volatile
Graham Number0.180.280.2812
Slightly volatile
Operating Cycle227170190
Pretty Stable
Price Book Value Ratio9.919.446.1249
Slightly volatile
Days Of Payables Outstanding71.3356.2438.2729
Slightly volatile
Ebt Per Ebit1.561.081.0389
Slightly volatile
Company Equity Multiplier1.551.861.358
Pretty Stable
Long Term Debt To Capitalization0.120.130.1362
Slightly volatile
Total Debt To Capitalization0.210.220.0886
Slightly volatile
Debt Equity Ratio0.290.270.1053
Slightly volatile
Quick Ratio2.662.044.4632
Slightly volatile
Net Income Per E B T1.011.150.8565
Slightly volatile
Cash Ratio1.621.22.8281
Very volatile
Cash Conversion Cycle11389.34147
Pretty Stable
Days Of Inventory Outstanding17795.56138
Very volatile
Days Of Sales Outstanding36.1858.5649.5772
Very volatile
Price To Book Ratio9.919.446.1249
Slightly volatile
Fixed Asset Turnover3.964.1711.0838
Pretty Stable
Debt Ratio0.330.170.0802
Slightly volatile
Price Sales Ratio4.954.723.9168
Slightly volatile
Asset Turnover1.531.421.3079
Slightly volatile
Gross Profit Margin0.460.570.5906
Pretty Stable
Price Fair Value9.919.446.1249
Slightly volatile

Repro Med Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap106 M101 M95.5 M
Slightly volatile
Enterprise Value99.4 M94.6 M89.2 M
Slightly volatile

Repro Fundamental Market Drivers

Forward Price Earnings188.6792
Cash And Short Term Investments9.6 M

Repro Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Repro Med Financial Statements

Repro Med stakeholders use historical fundamental indicators, such as Repro Med's revenue or net income, to determine how well the company is positioned to perform in the future. Although Repro Med investors may analyze each financial statement separately, they are all interrelated. For example, changes in Repro Med's assets and liabilities are reflected in the revenues and expenses on Repro Med's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Repro Med Systems. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM2.1 M
Total Revenue38.7 M40.6 M
Cost Of Revenue14.2 M14.9 M
Stock Based Compensation To Revenue 0.07  0.07 
Research And Ddevelopement To Revenue 0.14  0.15 
Capex To Revenue 0.03  0.03 
Revenue Per Share 0.66  0.69 
Ebit Per Revenue(0.22)(0.21)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:
Check out the analysis of Repro Med Correlation against competitors.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Will Health Care Equipment & Supplies sector continue expanding? Could Repro diversify its offerings? Factors like these will boost the valuation of Repro Med. Expected growth trajectory for Repro significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repro Med data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.66)
Earnings Share
(0.08)
Revenue Per Share
0.848
Quarterly Revenue Growth
0.272
Return On Assets
(0.09)
Repro Med Systems's market price often diverges from its book value, the accounting figure shown on Repro's balance sheet. Smart investors calculate Repro Med's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Repro Med's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Repro Med's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Repro Med represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.